Literature DB >> 16015444

Relationship of extent and nature of dysfunctional myocardium to brain natriuretic peptide in patients with ischemic left ventricular dysfunction.

Charles A Nelson1, Colin Case, Jane McCrohon, Thomas H Marwick.   

Abstract

We studied the relationship between brain natriuretic peptide (BNP) levels and viable myocardium and ischemic myocardium, regional scar and regional contractile function. Fifty-nine patients underwent dobutamine echocardiography and magnetic resonance imaging and resting BNP levels were determined. By magnetic resonance imaging, total extent of dysfunctional myocardium correlated strongest with BNP (r = 0.60, p < 0.0001). The extent of scar, viability and ischemia also correlated. At dobutamine echocardiography, a composite of dysfunctional and ischemic myocardium was the strongest correlate of BNP (r = 0.48, p < 0.0001), with less strong correlations by global parameters. The extent of dysfunctional myocardium, rather than its nature determines BNP levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16015444     DOI: 10.1007/s10554-004-3565-5

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  27 in total

Review 1.  Unmet need for diagnosis of heart failure: the view from primary care.

Authors:  F D R Hobbs
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

2.  Augmented release of brain natriuretic peptide during reperfusion of the human heart after cardioplegic cardiac arrest.

Authors:  P Mair; J Mair; J Bleier; C Hörmann; D Balogh; B Puschendorf
Journal:  Clin Chim Acta       Date:  1997-05-06       Impact factor: 3.786

3.  Interpretation of creatinine clearance.

Authors:  M M Elseviers; G A Verpooten; M E De Broe; G G De Backer
Journal:  Lancet       Date:  1987-02-21       Impact factor: 79.321

4.  Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise.

Authors:  W Friedl; J Mair; S Thomas; M Pichler; B Puschendorf
Journal:  Clin Chim Acta       Date:  1999-03       Impact factor: 3.786

5.  Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population.

Authors:  A Luchner; J C Burnett; M Jougasaki; H W Hense; I M Heid; F Muders; G A Riegger; H Schunkert
Journal:  J Hypertens       Date:  2000-08       Impact factor: 4.844

6.  B-type natriuretic peptide (BNP)--validation of an immediate response assay.

Authors:  M Vogeser; K Jacob
Journal:  Clin Lab       Date:  2001       Impact factor: 1.138

7.  Biochemical detection of left-ventricular systolic dysfunction.

Authors:  T A McDonagh; S D Robb; D R Murdoch; J J Morton; I Ford; C E Morrison; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

8.  Plasma brain natriuretic peptide concentration: impact of age and gender.

Authors:  Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

9.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Authors:  H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

10.  Impact of scar thickness on the assessment of viability using dobutamine echocardiography and thallium single-photon emission computed tomography: a comparison with contrast-enhanced magnetic resonance imaging.

Authors:  Charles Nelson; Jane McCrohon; Frederick Khafagi; Stephen Rose; Rodel Leano; Thomas H Marwick
Journal:  J Am Coll Cardiol       Date:  2004-04-07       Impact factor: 24.094

View more
  5 in total

Review 1.  Neurohormonal modulation in heart failure of ischemic etiology: correlates with left ventricular remodeling.

Authors:  Roberto Latini; Serge Masson; Lidia Staszewsky; Simona Barlera
Journal:  Curr Heart Fail Rep       Date:  2006-12

2.  Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair.

Authors:  Harm H H Feringa; Don Poldermans; Patrick Klein; Jerry Braun; Robert J M Klautz; Ron T van Domburg; Arnoud van der Laarse; Ernst E van der Wall; Robert A E Dion; Jeroen J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2006-08-29       Impact factor: 2.357

3.  The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis.

Authors:  Namik Kemal Eryol; Ali Dogan; Ibrahim Ozdogru; Mehmet Tugrul Inanc; Mehmet Gungor Kaya; Nihat Kalay
Journal:  Int J Cardiovasc Imaging       Date:  2006-12-21       Impact factor: 2.357

4.  The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients.

Authors:  Ceyhun Ceyhan; Selim Unal; Cigdem Yenisey; Tarkan Tekten; F Banu Ozturk Ceyhan
Journal:  Int J Cardiovasc Imaging       Date:  2007-08-09       Impact factor: 2.357

5.  Correlation between plasma N-terminal pro-brain natriuretic peptide levels and changes in New York Heart Association functional class, left atrial size, left ventricular size and function after mitral and/or aortic valve replacement.

Authors:  Abdelfatah Elasfar
Journal:  Ann Saudi Med       Date:  2012 Sep-Oct       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.